Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Krystal Biotech, Inc. | 1,476,173 | reported | 04 Mar 2026 | tx 256+918,189−1,289,400 |
| NEW RIVER PHARMACEUTICALS INC | 119,280 | reported | 25 Jan 2007 | tx 34+1,859,100−596,800 |
| PRECIGEN, INC. | 56,657 | reported | 29 Jan 2016 | tx 12+634,214−134,214 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 Mar 2026 | SALE | Krystal Biotech, Inc. | 483 | 257.31 USD | |
| 04 Mar 2026 | SALE | Krystal Biotech, Inc. | 470 | 258.38 USD | |
| 04 Mar 2026 | SALE | Krystal Biotech, Inc. | 1,377 | 259.87 USD | |
| 04 Mar 2026 | SALE | Krystal Biotech, Inc. | 3,128 | 260.49 USD | |
| 04 Mar 2026 | SALE | Krystal Biotech, Inc. | 920 | 266.56 USD | |
| 04 Mar 2026 | SALE | Krystal Biotech, Inc. | 2,380 | 262.44 USD | |
| 04 Mar 2026 | SALE | Krystal Biotech, Inc. | 2,043 | 263.70 USD | |
| 04 Mar 2026 | SALE | Krystal Biotech, Inc. | 8,798 | 264.85 USD | |
| 04 Mar 2026 | SALE | Krystal Biotech, Inc. | 2,439 | 265.59 USD | |
| 04 Mar 2026 | SALE | Krystal Biotech, Inc. | 2,962 | 261.41 USD | |
| 27 Feb 2026 | EXERCISE | Krystal Biotech, Inc. | 26,250 | 0.00 USD | |
| 27 Feb 2026 | TAX_WITHHOLDING | Krystal Biotech, Inc. | 1,820 | 275.64 USD | |
| 27 Feb 2026 | EXERCISE | Krystal Biotech, Inc. | 8,750 | 0.00 USD | |
| 27 Feb 2026 | TAX_WITHHOLDING | Krystal Biotech, Inc. | 3,981 | 275.64 USD | |
| 27 Feb 2026 | TAX_WITHHOLDING | Krystal Biotech, Inc. | 11,942 | 275.64 USD | |
| 27 Feb 2026 | EXERCISE | Krystal Biotech, Inc. | 5,725 | 0.00 USD | |
| 27 Feb 2026 | TAX_WITHHOLDING | Krystal Biotech, Inc. | 2,605 | 275.64 USD | |
| 27 Feb 2026 | EXERCISE | Krystal Biotech, Inc. | 22,500 | 0.00 USD | |
| 27 Feb 2026 | TAX_WITHHOLDING | Krystal Biotech, Inc. | 10,236 | 275.64 USD | |
| 27 Feb 2026 | EXERCISE | Krystal Biotech, Inc. | 4,000 | 0.00 USD | |
| 27 Feb 2026 | EXERCISE | Krystal Biotech, Inc. | 26,250 | 0.00 USD | deriv |
| 27 Feb 2026 | GRANT_AWARD | Krystal Biotech, Inc. | 45,249 | 0.00 USD | deriv |
| 27 Feb 2026 | GRANT_AWARD | Krystal Biotech, Inc. | 18,140 | 0.00 USD | deriv |
| 27 Feb 2026 | EXERCISE | Krystal Biotech, Inc. | 8,750 | 0.00 USD | deriv |
| 27 Feb 2026 | EXERCISE | Krystal Biotech, Inc. | 5,725 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 22 Sept 2017.